Sort
16,179 grants matching “malaria”
International Clinical Trials Unit
$996,650Duke University · U01 · FY2004 · AI
SBIR Phase II: Stable Prophylactic Antibodies
$996,606Arthur Young · Invvax, Inc. · · FY2025 · TIP
Malaria immunology
$996,334Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.
$996,292Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2017 · AI
AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans
$996,178Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2018 · HG
Prostate Cancer Studies
$995,563Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites
$995,482Sumana Chakravarty · Sanaria, Inc. · U44 · FY2024 · AI
Babesia antigen detection assay for blood screening
$995,189Andrew E. Levin · Immunetics, Inc. · R44 · FY2016 · HL
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine
$995,117Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2011 · AI
Progressing PfSPZ vaccines for malaria to licensure and commercialization
$995,072Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2025 · AI
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$994,901Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
III: Medium: Algorithms and Software Tools for Epigenetics Research
$994,370Stefano Lonardi · University Of California-Riverside · · FY2013 · CSE
Preclinical development of novel small molecule malaria drugs that overcome drug
$994,275David H Peyton · Designmedix, Inc. · R42 · FY2016 · AI
Attenuated Sporozoite Malaria Vaccine
$993,547Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2009 · AI
Attenuated Sporozoite Malaria Vaccine
$993,465Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
Cryopreservation and delivery of sporozoite vaccine
$993,429Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$993,079Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$993,003Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Attenuated Sporozoite Malaria Vaccine
$992,988Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
Malarial retinopathy screening system for improved diagnosis of cerebral malaria
$992,940Vinayak S Joshi · Visionquest Biomedical Inc · SB1 · FY2022 · AI
MIT Laser Biomedical Research Center (P41-RR02594)
$992,896Peter T. So · Massachusetts Institute Of Technology · P41 · FY2016 · EB
Host Immune Responses to Antigens of Malaria Parasites
$992,457Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Malaria Pathogenesis and Human Immunity
$992,443Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Preclinical development of a potent D-peptide RSV inhibitor
$992,263Brett D Welch · Navigen, Inc. · R44 · FY2016 · AI
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
$991,947Michelle M. Butler · Microbiotix, Inc · R44 · FY2020 · AI